C

China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570

Watchlist Manager
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
Watchlist
Price: 2.29 HKD 0.44% Market Closed
Market Cap: 11.5B HKD
Have any thoughts about
China Traditional Chinese Medicine Holdings Co Ltd?
Write Note

China Traditional Chinese Medicine Holdings Co Ltd
Cash Interest Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

China Traditional Chinese Medicine Holdings Co Ltd
Cash Interest Paid Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Interest Paid CAGR 3Y CAGR 5Y CAGR 10Y
C
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
Cash Interest Paid
ÂĄ179.7m
CAGR 3-Years
-17%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
G
Grand Pharmaceutical Group Ltd
HKEX:512
Cash Interest Paid
HK$204.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
U
United Laboratories International Holdings Ltd
HKEX:3933
Cash Interest Paid
ÂĄ69.5m
CAGR 3-Years
2%
CAGR 5-Years
-19%
CAGR 10-Years
-16%
Sino Biopharmaceutical Ltd
HKEX:1177
Cash Interest Paid
ÂĄ480.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
China Resources Pharmaceutical Group Ltd
HKEX:3320
Cash Interest Paid
HK$2.5B
CAGR 3-Years
-3%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
H
HUTCHMED (China) Ltd
HKEX:13
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

China Traditional Chinese Medicine Holdings Co Ltd
Glance View

Market Cap
11.5B HKD
Industry
Pharmaceuticals

China Traditional Chinese Medicine Holdings Co Ltd sits at the crossroads of ancient wisdom and modern commerce. Rooted deeply in the rich heritage of Traditional Chinese Medicine (TCM), this company skillfully crafts a range of products that cater to both domestic and international markets. At the core of its operations is the cultivation and processing of Chinese medicinal herbs, which are transformed into a wide portfolio of products, including ready-to-use TCM formula granules, patented medicines, and healthcare products. By leveraging its extensive network of cultivation bases, the company ensures the authenticity and quality of its raw materials, an essential component in a sector where the efficacy of products is deeply entwined with their origins. The company’s business model thrives on vertical integration, which allows it to exercise control over the entire supply chain—from the sourcing of raw materials to the manufacturing and distribution processes. Through this multifaceted approach, China Traditional Chinese Medicine Holdings Co Ltd maximizes its profit margins while maintaining stringent quality standards, crucial in a market where consumer trust is paramount. The firm's robust distribution network spans pharmacies, hospitals, and retail outlets, supplemented by a growing e-commerce presence. As healthcare trends increasingly lean towards natural and holistic remedies around the globe, the company finds itself well-positioned to not only cater to traditional markets but also to explore new opportunities in alternative medicine sectors worldwide.

Intrinsic Value
4.12 HKD
Undervaluation 44%
Intrinsic Value
Price
C

See Also

What is China Traditional Chinese Medicine Holdings Co Ltd's Cash Interest Paid?
Cash Interest Paid
179.7m CNY

Based on the financial report for Jun 30, 2024, China Traditional Chinese Medicine Holdings Co Ltd's Cash Interest Paid amounts to 179.7m CNY.

What is China Traditional Chinese Medicine Holdings Co Ltd's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 5Y
-9%

Over the last year, the Cash Interest Paid growth was -1%. The average annual Cash Interest Paid growth rates for China Traditional Chinese Medicine Holdings Co Ltd have been -17% over the past three years , -9% over the past five years .

Back to Top